Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

Savino Sciascia; Piera Costanzo; Massimo Radin; Karen Schreiber; Massimo Pini; Antonella Vaccarino; Irene Cecchi; Simone Baldovino; Dario Roccatello

doi:10.1016/S2665-9913(21)00320-9

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

Savino Sciascia^*, Piera Costanzo, Massimo Radin, Karen Schreiber, Massimo Pini, Antonella Vaccarino, Irene Cecchi, Simone Baldovino, Dario Roccatello

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	e832
Tidsskrift	The Lancet Rheumatology
Vol/bind	3
Udgave nummer	12
Antal sider	1
ISSN	2665-9913
DOI	https://doi.org/10.1016/S2665-9913(21)00320-9
Status	Udgivet - 1. dec. 2021

Dokumenter og links

10.1016/S2665-9913(21)00320-9Licens: Ikke-specificeret

Citationsformater

@article{8b762923b55a4b24bc8979c5fba487de,

title = "Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies",

author = "Savino Sciascia and Piera Costanzo and Massimo Radin and Karen Schreiber and Massimo Pini and Antonella Vaccarino and Irene Cecchi and Simone Baldovino and Dario Roccatello",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/S2665-9913(21)00320-9",

language = "English",

volume = "3",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies

AU - Sciascia, Savino

AU - Costanzo, Piera

AU - Radin, Massimo

AU - Schreiber, Karen

AU - Pini, Massimo

AU - Vaccarino, Antonella

AU - Cecchi, Irene

AU - Baldovino, Simone

AU - Roccatello, Dario

PY - 2021/12/1

Y1 - 2021/12/1

U2 - 10.1016/S2665-9913(21)00320-9

DO - 10.1016/S2665-9913(21)00320-9

M3 - Comment/debate

C2 - 34697607

AN - SCOPUS:85119611545

SN - 2665-9913

VL - 3

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 12

M1 - e832

ER -